Tuna Özgecan, Ermiş Çağatay, Enez Darçın Aslı, Dağıstan Ekin, Akkoş Recep, Aksoy Umut Mert, Tabak Ömür, Kocataş Ali
Kanuni Sultan Süleyman Training and Research Hospital, Department of Adult Psychiatry Atakent Mh, Turgut Özal Bulvari No:46/1, 34303 Küçükçekmece, İstanbul, Turkey,
Psychiatr Danub. 2022 Winter;34(4):781-789. doi: 10.24869/psyd.2022.781.
High levels of anxiety and depression symptoms have been reported in patients with COVID-19 compared to the general population. These symptoms were related to variables such as gender, age, and education level with anxiety/depression levels. We aimed to determine the relationship between anxiety and depression symptoms and epidemic-related decreased functioning, worry, and quality of life (QoL).
The study included 238 hospitalized participants due to COVID-19 and 168 participants who were hospitalized for reasons other than COVID-19. The Hospital Anxiety and Depression Scale (HADS), Short Form 36 (SF-36) QoL Scale, and questionnaires prepared by the researchers were applied. The effects of current worries, impairment in QoL, and decreased functioning during quarantine on levels of anxiety and depressive symptoms were investigated by implementing multiple linear regression analyzes.
Our study results suggested the anxiety and depression levels of patients with COVID-19 were not higher than those in the internal medicine inpatient unit at the same time. Worries about transmission to others, uncertainty, social media news, and health anxiety increased the psychiatric symptoms of participants with COVID-19. Disruptions in social relationships and health also have an effect on anxiety/depression symptom levels. Conversely, results indicated losses and worries in occupation and finance did not significantly affect mental symptoms.
Worries about transmission to others, uncertainty and health anxiety are closely related to anxiety and depression among patients with COVID-19. There is a need for research in the mental health field for the later stages of the pandemic in different cultures.
与普通人群相比，新型冠状病毒肺炎（COVID-19）患者中焦虑和抑郁症状水平较高。这些症状与性别、年龄和教育水平等变量以及焦虑/抑郁水平有关。我们旨在确定焦虑和抑郁症状与疫情相关的功能下降、担忧和生活质量（QoL）之间的关系。
该研究纳入了238名因COVID-19住院的参与者以及168名因COVID-19以外原因住院的参与者。应用了医院焦虑抑郁量表（HADS）、简明健康状况调查量表（SF-36）生活质量量表以及研究人员编制的问卷。通过进行多元线性回归分析，研究了当前担忧、生活质量受损以及隔离期间功能下降对焦虑和抑郁症状水平的影响。
我们的研究结果表明，COVID-19患者的焦虑和抑郁水平并不高于同期内科住院病房的患者。对传染给他人的担忧、不确定性、社交媒体新闻以及健康焦虑增加了COVID-19患者的精神症状。社会关系和健康方面的破坏也对焦虑/抑郁症状水平有影响。相反，结果表明职业和财务方面的损失和担忧对精神症状没有显著影响。
对传染给他人的担忧、不确定性和健康焦虑与COVID-19患者的焦虑和抑郁密切相关。在不同文化背景下，针对疫情后期的心理健康领域有必要开展研究。
